Science Daily - Heart Disease

MARCH 20, 2024

Treating anxiety and depression significantly reduced hospital readmission and emergency room visits in people with heart disease.This may be the first study to show that treating anxiety and depression with medication or psychotherapy has a significant impact on heart disease outcomes.

Heart Disease 122

Heart Disease Hospital Outcomes 122

Heart BMJ

FEBRUARY 12, 2025

Background Atrial arrhythmias (AA) and heart failure (HF) are major causes of hospitalisation in adult congenital heart disease (ACHD). Dates of first AA and HF presentations were documented, and outcomes of RFA, including acute and long-term success, were assessed.

Congenital Heart Disease 59

Congenital Heart Disease Congenital Heart Failure Arrhythmia 59

Open Heart

MARCH 25, 2025

Aim To assess the effectiveness and safety of strength training (ST) interventions in people with congenital heart disease (ConHD). Although the outcomes are positive, there is still insufficient evidence to establish the clinical significance of ST.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Outcomes 52

Frontiers in Cardiovascular Medicine

JANUARY 28, 2025

BackgroundThe efficacy and mechanism of Fufang Danshen dripping pills (FFDS) in the secondary prevention of stable coronary heart disease (SCHD) is currently undetermined. After treatment, three-months major adverse cardiovascular events (MACE) were assessed as the primary outcome.

Heart Disease 52

Heart Disease Angina Cholesterol Pharmacology 52

Dr. Paddy Barrett

JANUARY 2, 2025

What is inside the Heart Health Formula? A step-step guide to: - Understanding Heart Disease. Defining Heart Disease Risk. Reducing Heart Disease Risk. The Heart Health Formula is made up of 3 main modules. Understanding Heart Disease. Heart Attack versus Heart Disease.

Cholesterol 89

Cholesterol Heart Disease Blood Pressure Coronary Angiogram 89

Frontiers in Cardiovascular Medicine

MARCH 28, 2025

IntroductionVentricular septal defect (VSD) is a common congenital heart disease (CHD), accounting for 2030% of all CHD cases. Procedural success, complications, and follow-up outcomes were assessed at 1, 3, 12, and 18 months post-procedure. Data were analyzed using SPSS 20.0.ResultsThe

VSD 52

VSD Outcomes Congenital Heart Disease Aortic valve 52

Med Page Today

DECEMBER 4, 2024

(MedPage Today) -- Serious outcomes associated with metabolic dysfunction-associated steatotic liver disease (MASLD) -- including liver cancer, cirrhosis, heart disease, and more -- affect men and women differently, a large cohort study of.

Outcomes 109

Outcomes Cancer Heart Disease 109

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2025

BackgroundCongenital heart disease (CHD) is a major contributor to morbidity and infant mortality and imposes the highest burden on global healthcare costs. Early diagnosis and prompt treatment of CHD contribute to enhanced neonatal outcomes and survival rates; however, there is a shortage of proficient examiners in remote regions.

Congenital Heart Disease 52

Congenital Heart Disease Heart Disease Ultrasound Congenital 52

Open Heart

MAY 23, 2024

Background and aims Pre-eclampsia complicates 3–5% of pregnancies worldwide and is associated with adverse outcomes for the mother and the offspring. Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes. It is not known whether heart failure increases the risk of pre-eclampsia.

Heart Disease 98

Heart Disease Heart Failure Risk Factors Obesity 98

DAIC

JUNE 11, 2024

milla1cf Tue, 06/11/2024 - 18:18 June 11, 2024 — Using an advanced artificial intelligence tool, researchers at the Icahn School of Medicine at Mount Sinai have identified rare coding variants in 17 genes that shed light on the molecular basis of coronary artery disease ( CAD ), the leading cause of morbidity and mortality worldwide.

Heart Disease 105

Heart Disease Coronary Artery Disease Research Laboratory 105

Circulation

FEBRUARY 22, 2024

Over the past decade, new research has advanced scientific knowledge of neurodevelopmental trajectories, factors that increase neurodevelopmental risk, and neuroprotective strategies for individuals with congenital heart disease. It also includes an updated algorithm for referral, evaluation, and management of individuals at high risk.

Congenital Heart Disease 75

Congenital Heart Disease Congenital Heart Disease Genetic predisposition 75

Science Daily - Heart Disease

JULY 25, 2024

3D-printed blood vessels, which closely mimic the properties of human veins, could transform the treatment of cardiovascular diseases.

Outcomes 124

Outcomes Technology Cardiovascular Disease 124

Dr. Paddy Barrett

AUGUST 30, 2024

Here are five things everyone should know about sleep and heart disease. Insulin resistance is a precursor condition to metabolic syndrome and type 2 diabetes, both major drivers of heart disease. When you have gotten all four crucial lifestyle factors wrong, you are only left with medications and procedures.

Heart Disease 111

Heart Disease Dementia Obesity Heart Attack 111

DAIC

JUNE 18, 2024

A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovascular disease within the next 30 years, according to two new science reports. to 61% of the U.S. population.

Heart Disease 105

Heart Disease Blood Pressure Stroke Strokes 105

Journal of the American Heart Association

JANUARY 9, 2025

Journal of the American Heart Association, Ahead of Print. Survivorship from congenital heart disease has improved rapidly secondary to advances in surgical and medical management. This is an updated report of the American Heart Association's previous publications on exercise in children.

Congenital Heart Disease 75

Congenital Heart Disease Congenital Exercise Heart Disease 75

Journal of the American Heart Association

SEPTEMBER 12, 2024

Due to improvements in recognition and management of their multisystem disease, the long‐term survival of infants, children, and adolescents with trisomy 21 and congenital heart disease now matches children with congenital heart disease and no genetic condition in many scenarios.

Congenital Heart Disease 71

Congenital Heart Disease Congenital Heart Disease Quality of Life 71

Frontiers in Cardiovascular Medicine

JANUARY 22, 2025

The primary outcome was survival at the follow-up evaluation. The time point designated as time 0 was defined as the time of heart transplantation. A higher mortality rate was observed among children under three months of age with congenital heart disease.

Heart Transplant 52

Heart Transplant Transplant Pediatrics Heart Failure 52

European Journal of Heart Failure

DECEMBER 11, 2024

Abstract Worldwide, valvular heart disease (VHD) is a common cause of hospitalization for acute heart failure. In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock.

Cardiogenic Shock 68

Cardiogenic Shock Heart Disease Heart Failure Bicuspid/Mitral 68

DAIC

JULY 12, 2024

This is paving the way for faster, non-invasive and more accurate diagnosis of heart failure and other cardiac conditions. Garg said: “The AI model precisely determined the size and function of the heart's chambers and demonstrated outcomes comparable to those acquired by doctors manually but much quicker.

Outcomes 122

Outcomes Hospital Research Innovation 122

Circulation

JANUARY 24, 2024

METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Stroke Strokes 81

Medical Xpress - Cardiology

FEBRUARY 21, 2024

Using intravascular imaging to guide stent implantation during percutaneous coronary intervention (PCI) in heart disease patients significantly improves survival and reduces adverse cardiovascular events compared to angiography-guided PCI alone, the most commonly used method.

Stent 114

Stent Stents Heart Disease Outcomes 114

American College of Cardiology

MARCH 11, 2024

The following are key points to remember from an American Heart Association Scientific Statement on neurodevelopmental outcomes for individuals with congenital heart disease, which includes updates in neuroprotection, risk-stratification, evaluation, and management.

Congenital Heart Disease 48

Congenital Heart Disease Congenital Heart Disease Outcomes 48

DAIC

JANUARY 6, 2025

6, 2025 Medtronic plc hasannounced it received CE ( Conformit Europenne ) Mark for the Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). Eur J Heart Fail.

Pulmonary 52

Pulmonary Congenital Heart Disease Open-Heart Surgery Congenital 52

Heart BMJ

SEPTEMBER 25, 2024

Congenital heart defects are the most common type of birth defect, affecting 1% of live births. The underlying cause of congenital heart disease is frequently unknown. However, advances in human genetics and genome technologies have helped expand congenital heart disease pathogenesis knowledge during the last few decades.

Congenital Heart Disease 59

Congenital Heart Disease Congenital Heart Disease Document 59

Circulation

FEBRUARY 28, 2024

It also sets out to advance this mission, focusing on how digital tools and, in particular, artificial intelligence may provide clinical and mechanistic insights, address bias in clinical studies, and facilitate education and implementation science to improve cardiovascular and stroke outcomes.

Best Practices 82

Best Practices Heart Disease Outcomes Education 82

Journal of the American Heart Association

FEBRUARY 28, 2024

Journal of the American Heart Association, Ahead of Print. The adjusted odds ratio (aOR) for the association of daily cannabis use and coronary heart disease, myocardial infarction, stroke, and the composite outcome (coronary heart disease, myocardial infarction, and stroke) was 1.16 (95% CI, 0.98–1.38),

Myocardial Infarction 76

Myocardial Infarction Outcomes Heart Disease Strokes 76

Heart BMJ

FEBRUARY 26, 2025

Primary outcome was new-onset CVD (self-reported heart disease/stroke) based on survey data at Wave 2 (2012–2015) and/or Wave 3 (2018–2020). Methods The Sax Institute’s 45 and Up Study prospectively recruited participants aged ≥45 years (n=267 357) between 2005 and 2009 (New South Wales, Australia).

Cardiovascular Disease 78

Cardiovascular Disease Diet Heart Disease Stroke 78

American College of Cardiology

JUNE 4, 2024

addressed the safety, tolerability, and outcomes of patients with adult congenital heart disease (ACHD) treated with sodium-glucose cotransporter 2 inhibitors (SGLT2i). Neijenhuis et al. and Fusco et al.

Congenital Heart Disease 58

Congenital Heart Disease Congenital Heart Disease Outcomes 58

Frontiers in Cardiovascular Medicine

MARCH 9, 2025

Heart transplantation is an effective treatment for end-stage heart disease, and postoperative patients' medication adherence is crucial for transplantation outcomes and long-term survival.

Heart Transplant 52

Heart Transplant Transplant Heart Disease Research 52

Cassling

MARCH 14, 2025

At the same time, the growing prevalence of complex cardiovascular conditions means assessing more nuanced, multifaceted presentations of heart disease. Heres a look at how AI ultrasound and other tech innovations are helping cardiologists work faster while driving better outcomes for patients.

Ultrasound 52

Ultrasound Innovation Heart Disease Outcomes 52

Stroke: Vascular and Interventional Neurology

OCTOBER 24, 2024

BackgroundAlthough many studies have examined the influence of individual preexisting heart conditions on stroke outcomes, the combined effects of these conditions remain understudied.MethodsThe data supporting this study's findings are available from the corresponding author upon reasonable request.

Heart Disease 40

Heart Disease Atrial Fibrillation Stroke Strokes 40

DAIC

JANUARY 29, 2024

years after SAVR to assess their outcomes. Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heart failure. By 2021 almost half of patients younger than 60 years were receiving TAVR rather than SAVR. The research team followed these patients for a median time of 2.4

Aortic valve 111

Aortic valve TAVR Aortic Outcomes 111

American College of Cardiology

MARCH 6, 2024

The following are key points to remember from an American Heart Association scientific statement on the use of artificial intelligence (AI) in improving outcomes in heart disease.

Heart Disease 42

Heart Disease Outcomes Article 42

Open Heart

DECEMBER 1, 2022

Background Screening programmes using echocardiography offer opportunity for intervention through identification and treatment of early (latent) rheumatic heart disease (RHD). We aimed to compare two methods for classifying progression or regression of latent RHD: serial review method and blinded, side-by-side review.

Heart Disease 52

Heart Disease Echocardiogram Outcomes 52

Frontiers in Cardiovascular Medicine

JULY 22, 2024

It will also discuss the clinical applications of MRI in diagnosing and monitoring placental insufficiency, as well as its implications for fetal growth restriction (FGR) and congenital heart disease (CHD).

Congenital Heart Disease 59

Congenital Heart Disease Congenital Heart Disease Biomarkers 59

Science Daily - Heart Disease

SEPTEMBER 23, 2024

A new observational study suggests the position in which responders initially place the two defibrillator pads on the body may make a significant difference in returning spontaneous blood circulation after shock from a defibrillator.

Defibrillator 120

Defibrillator Cardiac Arrest Outcomes Circulation 120

Frontiers in Cardiovascular Medicine

MARCH 19, 2024

Introduction Carcinoid heart disease (CHD), a complication of carcinoid syndrome (CS), is a rare condition that can lead to right sided valvular heart disease and has been traditionally associated with a poor prognosis. Results A total of 36 articles were included in the systematic review analysis.

Heart Disease 59

Heart Disease Tricuspid Biomarkers Article 59